Browse 11 Pharmaceutical companies funded by HSG. See funding amounts, founder contacts, and investment details.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Deep Intelligent Pharma is a Singapore based AI Clinical Trial Company
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
Full-Life Technologies is a medical company providing development, production, and commercialization of medicines for cancer therapy.
METiS Pharmaceuticals is the world's first AI-driven drug formulation company.
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
View all companies funded by HSG across every industry and funding stage.
View Full HSG Portfolio